Disclosures for "Clinical and Paraclinical Features Distinguishing Paraneoplastic from Immune Checkpoint Inhibitor-induced Encephalitis"
-
Miss Zhao has nothing to disclose.
-
Miss Benderoth has nothing to disclose.
-
Dr. Habis has nothing to disclose.
-
Dr. El-Zibaoui has nothing to disclose.
-
Dr. Venkatesan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. The institution of Dr. Venkatesan has received research support from NIH. The institution of Dr. Venkatesan has received research support from U.S. DOD.
-
Dr. Probasco has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Clinician. The institution of Dr. Probasco has received research support from Roche/Genentech.